Bristol-Myers Squibb
(ETR) BRM
Bristol-Myers Squibb Financials at a Glance
Market Cap
$101.84B
Revenue (TTM)
$48.19B
Net Income (TTM)
$7.05B
EPS (TTM)
$3.09
P/E Ratio
16.17
Dividend
$2.15
Beta (Volatility)
-0.03 (Low)
Dividend
$2.15
Beta (Volatility)
-0.03 (Low)
Price
$51.39
Volume
303
Open
$51.03
Price
$51.39
Volume
303
Open
$51.03
Previous Close
$51.39
Daily Range
$51.03 - $51.40
52-Week Range
$36.60 - $58.20
Dividend
$2.15
Beta (Volatility)
-0.03 (Low)
Price
$51.39
Volume
303
Open
$51.03
Previous Close
$51.39
Daily Range
$51.03 - $51.40
52-Week Range
$36.60 - $58.20
BRM News
BRM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bristol-Myers Squibb
Industry
Pharmaceuticals
Sector
Health CareEmployees
32,500
CEO
Christopher S. Boerner, PhD, MBA
Website
www.bms.comHeadquarters
Princeton, NY 10016, US
BRM Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
26%
Net Income Margin
15%
Return on Equity
40%
Return on Capital
19%
Return on Assets
8%
Earnings Yield
6.18%
Dividend Yield
0.04%
Payout Ratio
71.53%
Stock Overview
Market Cap
$101.84B
Shares Outstanding
2.04B
Volume
303
Short Interest
0.00%
Avg. Volume
2.57K
Financials (TTM)
Gross Profit
$34.95B
Operating Income
$14.99B
EBITDA
$19.24B
Operating Cash Flow
$14.16B
Capital Expenditure
$1.31B
Free Cash Flow
$12.85B
Cash & ST Invst.
$10.67B
Total Debt
$47.14B
Bristol-Myers Squibb Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.50B
+1.3%
Gross Profit
$9.10B
+20.8%
Gross Margin
72.78%
N/A
Market Cap
$101.84B
N/A
Market Cap/Employee
$2.99M
N/A
Employees
34,100
N/A
Net Income
$1.09B
+1408.4%
EBITDA
$4.66B
+82.8%
Quarterly Fundamentals
Net Cash
$36.47B
+9.6%
Accounts Receivable
$14.53B
+0.7%
Inventory
$2.69B
+5.2%
Long Term Debt
$44.68B
-8.8%
Short Term Debt
$2.46B
+10.6%
Return on Assets
7.83%
N/A
Return on Invested Capital
19.06%
N/A
Free Cash Flow
$1.60B
-60.5%
Operating Cash Flow
$1.97B
-55.5%